Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Breast Cancer × Clinical Protocols × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Locally Advanced Breast Cancer 1

Interventions

pertuzumab 2 Paclitaxel 2 Neoadjuvant Therapy 2 Docetaxel 2 Carboplatin 2 pyrotinib 1 pegfilgrastim 1 Trastuzumab 1 Mastectomy, Modified Radical 1 Letrozole 1 Hydralazine 1 Doxorubicin 1 Cyclophosphamide 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05749016 2023-03-01

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡